Prognostic value of PD-L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer

被引:3
|
作者
Zou, Yunlian [1 ,2 ]
Wang, Jinli [2 ,3 ]
Zhang, Jinping [1 ,2 ]
Guo, Qiang [2 ,3 ]
Song, Zhengji [2 ,3 ,4 ]
Tang, Hui [2 ,3 ,4 ]
机构
[1] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Hematol, Kunming 650032, Yunnan, Peoples R China
[2] Kunming Univ Sci & Technol, Med Fac, Kunming 650504, Yunnan, Peoples R China
[3] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Dept Gastroenterol, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China
[4] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Gastroenterol, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; multiplex immunohistochemistry; programmed death receptor ligand 1; cluster of differentiation 68; prognosis biomarker; DEATH-LIGAND; 1; INFILTRATING LYMPHOCYTES; SIGNIFICANT PREDICTOR; CD133; EXPRESSION; SURVIVAL; OVEREXPRESSION; PROGRESSION; CARCINOMA; PATHWAY; MARKER;
D O I
10.3892/ol.2023.14153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The programmed death receptor 1/programmed death receptor ligand 1 axis (PD-1/PD-L1) is involved in tumor immune escape and is a potential prognostic biomarker and anti-tumor immunotherapy target in patients with gastric cancer (GC). However, the results of studies obtained in recent years have been inconsistent. The present study aimed to determine the possible predictive significance of PD-L1 in conjunction with three proteins linked with PD-L1 regulation in patients with primary GC. In the present study, the PD-L1, human epidermal growth factor receptor 2 (HER2), cluster of differentiation (CD)133 and microphage-associated CD68 expression levels were identified by multiplexed immunohistochemistry and assessed by automated pathological analysis system in 93 GC tumors and neighboring normal tissues arrayed on the same tissue microarray. All four proteins were statistically analyzed in relation to the clinicopathological characteristics. The expression levels of HER2, CD133 and CD68 were considerably higher in cancer tissues compared with neighboring normal tissues (P<0.05), however, the reverse trend was detected for PD-L1 expression (P=0.0577), particularly in tumor nest (TN; P<0.05). There was no significant correlation between the HER2 and CD133 expression levels and clinicopathological factors. However, significant relationships were found between PD-L1 expression and the TNM stage, pathological differentiation and survival status of patients (P<0.05). Moreover, survival time was prolonged in individuals with elevated PD-L1 expression in TN and GC tissues, but no significant correlation was identified (P=0.0881). The CD68 expression level in tumor stroma, but not in TN, was significantly correlated with poor pathological differentiation in patients with GC (P<0.05). However, PD-L1+CD68+ macrophages were strongly related to lower tumor size (diameter <5 cm), early TNM stage (stage I+II), good pathological differentiation and overall survival in TN (P<0.05). In conclusion, PD-L1+CD68+ macrophage infiltration in TN might be a potential indicator of prognosis in patients with primary GC and merits further investigation.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Prognostic Significance of Categorizing Gastric Carcinoma by PD-L1 Expression and Tumor Infiltrating Lymphocytes
    Noh, Byeong-Joo
    Kim, Ji Hoon
    Eom, Dae-Woon
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2018, 48 (06): : 695 - 706
  • [42] Prognostic impact of PD-1, PD-L1, and CD8 genes expression in peripheral blood in gastric cancer.
    Ito, Shuhei
    Masuda, Takaaki
    Fukagawa, Takeo
    Kouyama, Yuta
    Wakiyama, Hiroaki
    Yoshikawa, Yukihiro
    Noda, Miwa
    Kidogami, Shinya
    Hu, Qingjiang
    Sato, Kuniaki
    Nambara, Sho
    Saito, Tomoko
    Sakimura, Shotaro
    Hayashi, Naoki
    Kuroda, Yousuke
    Eguchi, Hidetoshi
    Sasako, Mitsuru
    Mimori, Koshi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] Expression and prognostic value of PD-1 and PD-L1 in colorectal carcinoma
    Aouadi, R.
    Helal, I.
    Khanchel, F.
    Hedhli, R.
    Ben Brahim, E.
    Jouini, R.
    Debbiche, A. Chadli
    VIRCHOWS ARCHIV, 2024, 485 : S151 - S152
  • [44] Prognostic value of tumor-infiltrating lymphocytes (TILs) and expression of PD-L1 in cholangiocarcinoma
    Suleiman, Yaman
    Coppola, Domenico
    Zibadi, Sherma
    Dalia, Samir
    Juan, TzuHua
    Lee, Jae K.
    Malafa, Mokenge Peter
    Soliman, Hatem Hussein
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [45] An Immunoscore Using PD-L1, CD68, and Tumor-infiltrating Lymphocytes (TILs) to Predict Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer
    McLemore, Lauren E.
    Janakiram, Murali
    Albanese, Joseph
    Shapiro, Nella
    Lo, Yungtai
    Zang, Xingxing
    Fineberg, Susan
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (09) : 611 - 619
  • [46] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [47] Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma
    Nie, Hanxiao
    He, Tao
    Wang, Li
    Zhang, Ling
    ONCOTARGETS AND THERAPY, 2021, 14 : 1377 - 1385
  • [48] Prognostic Value of PD-L1 in Patients with Hepatocellular Carcinoma
    Pei, Renguang
    Zhang, Weixuan
    Wang, Sufen
    Huang, Xi
    Zou, Yinghua
    CLINICAL LABORATORY, 2019, 65 (05) : 693 - 698
  • [49] PD-L1 expression in patients with metastatic gastric cancer in South Korea
    Kim, Hyo Song
    Wu, Ting
    Kim, Hyunki
    Chung, Hyun Cheol
    Ajani, Jaffer A.
    Ku, Geoffrey Yuyat
    Kelsen, David Paul
    Zhu, Xingshu
    Savage, Mary J.
    Koshiji, Minori
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Assessing Expression of PD-L1 in Tumor-Associated Macrophages
    Zhang, Jia
    Fu, Junke
    Zhang, Guangjian
    JAMA ONCOLOGY, 2020, 6 (10) : 1634 - 1635